Mandatory naltrexone treatment prevents relapse among opiate-dependent anesthesiologists returning to practice

Journal of Addiction Medicine

Volumn 5, Issue 4, 2011, Pages 279-283

  Merlo, Lisa J ^a,b   Greene, William M ^a   Pomm, Raymond ^c  

^a UNIVERSITY OF FLORIDA   (United States)

^b WASHINGTON UNIVERSITY   (United States)

^c Professionals Resource Network Inc   (United States)

Author keywords

Anesthesiologists; Impaired physician; Naltrexone; Opioid dependence; Relapse

Indexed keywords

NALTREXONE;

ADULT; ALCOHOL ABUSE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG MONITORING; FEMALE; HUMAN; MALE; MANDATORY PROGRAM; MEDICAL RECORD REVIEW; OPIATE ADDICTION; OPIATE SUBSTITUTION TREATMENT; PATIENT ATTITUDE; PATIENT MONITORING; PRIORITY JOURNAL; SUBSTANCE ABUSE; TREATMENT OUTCOME;

ADULT; ANESTHESIOLOGY; CONTRACTS; DRUG EVALUATION, PRECLINICAL; FEMALE; FLORIDA; FOLLOW-UP STUDIES; HUMANS; INTERNSHIP AND RESIDENCY; MALE; MANDATORY PROGRAMS; MIDDLE AGED; NALTREXONE; NARCOTIC ANTAGONISTS; OPIATE SUBSTITUTION TREATMENT; OPIOID-RELATED DISORDERS; PHYSICIAN IMPAIRMENT; RECURRENCE; REHABILITATION, VOCATIONAL;

EID: 84856937087     PISSN: 19320620     EISSN: 19353227     Source Type: Journal    
DOI: 10.1097/ADM.0b013e31821852a0     Document Type: Article

References (16)

1. Alexander BH, Checkoway H, Nagahama SI, et al. Cause-specific mortality risks of anesthesiologists. Anesthesiology 2000;93:922-930.
2. Baird WL, Morgan M. Substance misuse amongst anaesthesiologists. Anaesthesia 2000;55:943-945.
3. Berge KH, Seppala MD, Lanier WL. The anesthesiology community's approach to opioid-and anesthetic-abusing personnel: time to change course. Anesthesiology 2008;109:762-764.
4. Collins GB. Chemical dependency treatment outcomes of residents in anesthesiology: results of a survey. Anesth Analg 2005;101:1457-1462. (Pubitemid 41531887)
5. Domino KB, Hornbein TF, Polissar NL, et al. Risk factors for relapse in health care professionals with substance use disorders. JAMA 2005;293:1453-1460. (Pubitemid 40393289)
6. DuPont RL, McLellan AT, Carr G, et al. How are addicted physicians treated? A national survey of Physician Health Programs. J Subst Abuse Treat 2009;37:1-7.
7. DuPont RL,McLellan AT,White WL, et al. Setting the standard for recovery: Physicians health programs. J Subst Abuse Treat 2009;36:159-171.
8. Foster J, Brewer C, Steele T. Naltrexone implants can completely prevent early (1-month) relapse after opiate detoxification: a pilot study of two cohorts totalling 101 patients with a note on naltrexone blood levels. Addict Biol 2003;8:211-217. (Pubitemid 36859662)
9. Gold MS, Melker RJ, Dennis DM, et al. Fentanyl abuse and dependence: further evidence for second hand exposure hypothesis. J Addict Dis 2006;25:15-21. (Pubitemid 43673087)
10. Hughes PH, Storr CL, Brandenburg N, et al. Physician substance use by medical specialty. J Addict Dis 1999;18:23-37. (Pubitemid 29206327)
11. Hulse GK, O'Neil G, Hatton M, et al. Use of oral and implantable naltrexone in the management of the opioid impaired physician. Anaesth Intensive Care 2003;31:196-201. (Pubitemid 36503835)
12. Kleber HD. Treatment of narcotic addicts. Psychiatr Med 1987;3: 389-418.
13. Lew EA. Mortality experience among anesthesiologists, 1954-1976. Anesthesiology 1979;51:195-199.
14. Litten RZ, Allen JP. Medications for alcohol, illicit drug, and tobacco dependence: an update of research findings. J Subst Abuse Treat 1999;16:105-112. (Pubitemid 29066420)
15. McAuliffe PF, Gold MS, Bajpai L, et al. Secondhand exposure to aerosolized intravenous anesthetics propofol and fentanyl may cause sensitization and subsequent opiate addiction among anesthesiologists and surgeons. Med Hypotheses 2006;66:874-882. (Pubitemid 43207639)
16. McLellan AT, Skipper GS, Campbell M, et al. Five year outcomes in a cohort study of physicians treated for substance use disorders in the United States. BMJ 2008;337:1-6.